Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus
- PMID: 3022711
Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus
Abstract
The acyclovir resistant mutant of varicella-zoster virus ACV-R (A 8) induced the same level of thymidine kinase activity in infected cells as the parent Kawaguchi strain. However, it induced less deoxycytidine kinase activity and did not induce phosphorylating activity for the nucleotide analogue, 9-(2 hydroxy-ethoxymethyl)-guanine-(acyclovir). Another acyclovir resistant mutant, ACV-R (A 4), which is cross-resistant to phosphonoacetate and is thought to be a viral DNA polymerase mutant, induced the same level of phosphorylating activities for thymidine, deoxycytidine and acyclovir as the parent strain. The altered substrate specificity of thymidine kinase induced by ACV-R (A 8) is concluded to confer resistance to acyclovir on ACV-R (A 8).
Similar articles
-
Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.Biken J. 1983 Mar;26(1):17-23. Biken J. 1983. PMID: 6312958
-
Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine.Antimicrob Agents Chemother. 2001 Jun;45(6):1629-36. doi: 10.1128/AAC.45.6.1629-1636.2001. Antimicrob Agents Chemother. 2001. PMID: 11353604 Free PMC article.
-
Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine.Biken J. 1986 Mar;29(1):11-7. Biken J. 1986. PMID: 3022709
-
Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.Pediatr Infect Dis J. 2008 Jan;27(1):75-7. doi: 10.1097/INF.0b013e3181598315. Pediatr Infect Dis J. 2008. PMID: 18162946 Review.
-
[Mechanisms of antiherpes drugs and drug resistant virus--effect of BVDU on varicella zoster virus replication].Rinsho Byori. 1985 Feb;33(2):148-57. Rinsho Byori. 1985. PMID: 2987573 Review. Japanese. No abstract available.
Cited by
-
"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.Clin Microbiol Rev. 1994 Jan;7(1):1-13. doi: 10.1128/CMR.7.1.1. Clin Microbiol Rev. 1994. PMID: 8118786 Free PMC article. Review.
-
Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.J Virol. 1991 Dec;65(12):6407-13. doi: 10.1128/JVI.65.12.6407-6413.1991. J Virol. 1991. PMID: 1658351 Free PMC article.
-
Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.Antimicrob Agents Chemother. 1988 Aug;32(8):1137-42. doi: 10.1128/AAC.32.8.1137. Antimicrob Agents Chemother. 1988. PMID: 2847643 Free PMC article.
-
Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.Antimicrob Agents Chemother. 1999 Oct;43(10):2412-6. doi: 10.1128/AAC.43.10.2412. Antimicrob Agents Chemother. 1999. PMID: 10508017 Free PMC article.